Skip to content

Freedom Inguinal Hernia Repair System Study

Freedom Inguinal Hernia Repair System Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01984996
Enrollment
100
Registered
2013-11-15
Start date
2013-12-31
Completion date
Unknown
Last updated
2016-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Inguinal Hernia

Brief summary

The primary objective of this study is to evaluate patient quality-of-life (QOL) after inguinal hernia repair. Carolinas Comfort Scale (CCS) assessments will be held at regular intervals. The secondary objective of the study is to follow short-term and long-term study-related complications/adverse events.

Interventions

DEVICEFreedom ProFlor Inguinal Hernia Implant

Sponsors

Insightra Medical, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Scheduled to undergo routine inguinal hernia repair * Competent to give consent * Clinically relevant inguinal hernia (classification: NYHUS I, II, IIIa) * Defect size at operation is between 5mm and 35mm * Diagnosed with unilateral, direct, indirect or mixed inguinal hernia * Primary hernia at the operative site * Male or female * Life expectancy of at least 12 months * At least 18 years of age

Exclusion criteria

* Signs of obvious local or systemic infection * Any previous surgery on the hernia operative site * Hernia is not in the inguinal area * Hernia is not identified as indirect or direct * Femoral hernias * Known collagen disorder * Presenting with unstable angina or NYHA class of IV * Known Pregnancy * Active drug user * Recurrence of a repair by any method * Patients with giant inguinoscrotal hernia or abdominal wall defect \>35 mm in diameter - e.g. large direct or combined inguinal hernia type Nyhus IIIb / EHS P L/M 1/2/3 * Immunosuppression, prednisone\>15 mg/day, active chemotherapy * End stage renal disease * Abdominal ascites * Skin infection in area of surgical field * BMI \>35 * Peritoneum cannot be closed

Design outcomes

Primary

MeasureTime frameDescription
Measure changes from baseline in Carolina Comfort Scale (CCS) scores at specified time intervals1 week, 3, 6, 9, 12, 18, 24, and 36 months.Measure quality of life for patients undergoing inguinal hernia repair.

Secondary

MeasureTime frameDescription
Evaluate the 14-day pain and medication log14 daysPatient will record pain score and medications for 14 consecutive days.

Other

MeasureTime frame
Study-related complications/adverse events3 years

Countries

Austria, Italy, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026